Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7335899

NCc1ccc(C(=O)Nc2ccc3cc(C=NN)ccc3c2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 4/20 0.49
▸ PLG P00747 4/20 0.47
▸ PLAT P00750 2/20 0.47
▸ KLKB1 P03952 2/20 0.47
▸ PRSS1 P07477 2/20 0.47
▸ TNIK Q9UKE5 1/20 0.43
▸ HTR2C P28335 1/20 0.39
▸ MCHR1 Q99705 1/20 0.39
▸ ESRRG P62508 1/20 0.39
▸ RAB9A P51151 4/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ F2 P00734 2/20 0.38
▸ TMPRSS6 Q8IU80 1/20 0.38
▸ KLK1 P06870 2/20 0.38
▸ KLK6 Q92876 2/20 0.38
▸ NR1H4 Q96RI1 1/20 0.38
▸ LOX P28300 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7344120 0.94 PLAU (0.58) PLAUPLGPLATKLKB1PRSS1
Trifluoroacetic Acid SCHEMBL7344126 0.94 PLAU (0.58) PLAUPLGPLATKLKB1PRSS1
SCHEMBL27570130 0.92 PLAU (0.56) PLAUPLGPLATKLKB1PRSS1
SCHEMBL7343081 0.86 PLAU (0.67) PLAUPLGPLATKLKB1PRSS1
SCHEMBL7343089 0.86 PLAU (0.67) PLAUPLGPLATKLKB1PRSS1
Trifluoroacetic Acid SCHEMBL7334595 0.82 ESRRG (0.43) PLAUPLGKLKB1PRSS1ESRRG
Trifluoroacetic Acid SCHEMBL7334580 0.82 ESRRG (0.43) PLAUPLGKLKB1PRSS1ESRRG
Trifluoroacetic Acid SCHEMBL7335043 0.82 F2 (0.38) PLAUMCHR1RAB9ANPC1MEN1
Trifluoroacetic Acid SCHEMBL7338119 0.82 PTGS1 (0.48) PLAUPLGPLATKLKB1PRSS1
Trifluoroacetic Acid SCHEMBL7338135 0.82 PTGS1 (0.48) PLAUPLGPLATKLKB1PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 — — US claimed
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 — — US disclosed
US-6284796-B1 NAPHTHAMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-09-04 — — US disclosed
US-6258822-B1 ENZYME INHIBITORS OF NAPHTHALENE AMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-07-10 — — US disclosed
EP-1000018-A2 UROKINASE INHIBITORS Abbott Laboratories (US) 2000-05-17 — — EP disclosed
WO-1999005096-A2 UROKINASE INHIBITORS ABBOTT LABORATORIES (US) 1999-02-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049374-A1 Urokinase inhibitors SERPINE1, PLAU, SERPINB1 PLAU 2/4885PLG 10/4885PLAT 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback